The introduction of Retatrutide ZPHC, at a concentration of 120mg, is creating considerable buzz within the weight loss community. This novel dual GIP and GLP-1 receptor medication suggests to deliver impressive improvements in fat loss compared to current therapies. Initial patient trials have shown significant reductions in body fat percentage, p